4Holman RR,Paul SK,Bethel MA. 10-year follow-up of intensive glucose control in type 2 diabetes[J].New England Journal of Medicine,2008,(04):1577-1589.
5Ismail-Beigi F,Moghissi ES. Glycemia management and cardiovascular risk in type 2 diabetes:an evolving perspective[J].Endocrine Practice,2008,(07):639-643.
6Fruenhwald-Sehuhes B,Kren W,Beuer J. Elevated serum Lentin comcentrations in Type 2 diabetic patients with nicroalbuminuria and macroalbuninuria[J].Metabolism-Clinical and Experimental,2006,(04):1290-1295.
7Lee M,Odov D,Sweeney G. Leptin induces rat glomerular mesangial cell hypertrophy,but does not regulate hyperplasia or apoptosis[J].Int J Obes(Lond),2005,(09):1395-1401.
8Fruebis J,Tsao TS,Javorschi S. Protoolytic cleavage product of 30-kD adipocyte complement-related protein increases fatty acid oxidatim in muscle and causes weight loss in mice[J].Proceedings of the National Academy of Sciences(USA),2001,(04):2005-2010.doi:10.1073/pnas.041591798.
9Hirose H,Kawai T,Yamatnato Y. Effects of pioglitazone on metabolic parameters,body fat distributi on,and serum adiponectin levels in Japanese male patients with type 2 diabetes[J].Metabolism-Clinical and Experimental,2002,(07):314-317.
10Weyer C,Funabashi T. Hypoadipo nectin in obesity and type 2 diabetes:close association with insulin resistance and hyperinsulinmia[J].J Clin Endocrinel Metdb,2006,(05):1930.
